Aquisição de BULEVIRTIDA 2 MG PÓ SOL INJ FR SC e NATALIZUMAB 150 MG/ML SOL INJ SER

ID 12181289 · Portal BASE
Price
Base Price
€109,359 .00
Effective Price
€30,100 .00 -72.5%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa
Bidder Count
—
Winner
BIOGEN PORTUGAL, SOC FARMACÊUTICA, UNIPESSOAL
NIF 506415740
Company
Dates
Publication
22 Dec 2025
Celebration
17 Dec 2025
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 10 · LOW RISK
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
109359.0
Total effective price
30100.0
Ratio
0.2752
Direction
reduction
Rule
A9 price reduction: ratio 0.2752 outside [0.5, 1.5]
Detected 2026-03-06